English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Synthetische Letalität als Therapiekonzept für die Behandlung maligner Neoplasien

MPS-Authors
/persons/resource/persons147191

Herter-Sprie,  Grit S.
Neuronal Control of Metabolism, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147147

Chen,  S.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147267

Reinhardt,  H. Christian
Neuronal Control of Metabolism, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Herter-Sprie, G. S., Chen, S., Höpker, K., & Reinhardt, H. C. (2011). Synthetische Letalität als Therapiekonzept für die Behandlung maligner Neoplasien. Deutsche Medizinische Wochenschrift, 136(30), 1526-1530. doi:10.1055/s-0031-1281549.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0026-D98D-5
Abstract
© 2011 Georg Thieme Verlag KG Stuttgart, New York.